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1. Introduction
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a
minimally invasive mediastinal sampling technique which combines the use of ultrasound
with conventional bronchoscopy in order to visualise and sample structures adjacent to the
tracheo-bronchial tree such as mediastinal and hilar lymph nodes. The technique is commonly
used in the staging and diagnosis of lung cancers but can also be used for the diagnosis of
benign conditions affecting the mediastinum including sarcoidosis.
In asymptomatic stage I sarcoidosis (bilateral hilar adenopathy) with evidence of arthritis and
erythema nodosum (Lofgren’s syndrome) it may be possible to make a presumptive diagnosis
based on clinical and radiological findings however in symptomatic patients and particularly
where immunosuppressive therapy is being considered or exclusion of other causes of
mediastinal lymphadenopathy is required (e.g. tuberculosis, histoplasmosis, silicosis or
lymphoma) a tissue diagnosis may be sought. A diagnosis of sarcoidosis can be made in the
presence of pathological evidence demonstrating non-caseating granulomata, in the absence
of positive mycobacterial and fungal cultures and with supporting clinical and radiological
evidence. Tissue for diagnosis should be obtained from the most accessible involved organ.
Since pulmonary sarcoidosis is the most frequent form, bronchoscopic techniques are often
the first line investigation.
Conventional flexible bronchoscopy is frequently performed in the diagnosis of sarcoidosis
but is of limited use when central or peripheral airways are not affected. Endobronchial biopsy
(EBB) where there is evidence of disease affecting the airways may assist with the diagnosis.
Transbronchial lung biopsy (TBLB) can be performed where there is evidence of parenchymal
disease however this technique carries a risk of bleeding and pneumothorax. Transbronchial
needle aspiration (TBNA) can be useful in the context of mediastinal lymphadenopathy
however this is a “blind” technique and as such diagnostic accuracy is variable and further
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more there is risk of bleeding and damage to vascular structures. There are also limitations in
terms of which nodes can be sampled using conventional TBNA. Mediastinoscopy remains
the gold standard approach for sampling the mediastinal glands, particularly when other
sampling techniques are non-diagnostic however this is an invasive procedure which requires
a general anesthetic and is associated with morbidity. Many of the limitations associated with
the aforementioned techniques can be overcome by the use of EBUS-TBNA. The following
chapter describes the technique, its application in the diagnosis of sarcoidosis and the advan‐
tages of EBUS-TBNA over alternative mediastinal sampling techniques.
2. EBUS –TBNA - Technical issues
2.1. The EBUS scope
There are two probes available. The radial probe was initially developed in 1992. This is a high
frequency probe (20-30MHz) which achieves a high resolution image but has limited depth
penetration (4-5cm) and provides a 360 degree view. The radial probe is particularly useful for
imaging of the airway wall however it does not allow real time identification of structures
during sampling (table 1). The convex or linear probe EBUS scope integrates a convex
transducer probe at the tip of a flexible bronchoscope (figure 1). The transducer has a frequency
of 7.5 MHz and scans through the airway wall in a plane which is parallel to the insertion
direction of the bronchoscope. Although images using the convex probe are of lower resolution
there is improved depth of penetration (up to 9cm) and most importantly this probe enables
real time imaging of the EBUS-TBNA needle throughout the sampling process thus reducing
the risk of damage to vascular structures. The endoscopic image is viewed at an angle of 30
degrees forward oblique and the operator needs to compensate accordingly. The ultrasonic
image is viewed at an angle of 90 degrees to the bronchoscope. The ultrasonic image of
mediastinal structures is obtained by making direct contact between the probe and the airway
wall. Improved image quality can be achieved by increasing the contact between the trans‐
ducer and the airway wall using a balloon attached to the tip of the ultrasound which is filled
with normal saline. The ultrasound image is processed and visualized with the conventional
bronchoscopic image, on the same monitor (figure 2). The ultrasonic image can be frozen and
the size of lesions or nodes can be measured in two dimensions. The use of colour flow and
power Doppler also allows accurate identification of vascular structures adjacent to or within
the area of interest. The linear probe is most commonly used in the sampling of mediastinal
lymph nodes. Unless specified, the term EBUS in this chapter refers to linear probe EBUS.
Radial Probe Convex Probe
Frequency 20-30MHz 7.5MHz
Penetration (cm) 4-5 9
Applications Assessment of airway wallSampling of peripheral lesions
Sampling of mediastinal lesions e.g.
lymph nodes
Table 1. Comparison of radial probe vs convex probe
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Figure 1. Linear EBUS probe
Figure 2. EBUS Scope Processor and Monitor
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EBUS-TBNA is sometimes performed at the same time as flexible bronchoscopy which may
be necessary when more detailed examination of the distal tracheobronchial tree or endo‐
bronchial biopsies are required. The external diameter of the EBUS-TBNA scope is wider than
a conventional bronchoscope (6.9mm compared with 5-6mm) however endobronchial biopsies
of more proximal airways can be carried out via the EBUS bronchoscope. As with flexible
bronchoscopy, EBUS-TBNA procedure is commonly performed under light conscious
sedation using intravenous midazolam and fentanyl as well as topical anaesthesia however
some centres prefer to use deep sedation with propofol or a remifentanil infusion with a
laryngeal mask airway in order to minimize coughing. Typically the procedure is carried out
as a day case. Adequate sedation is essential as EBUS-TBNA takes longer than a flexible
bronchoscopy, particularly if multiple nodal stations are sampled. The patient is positioned in
a supine position and the bronchoscopist stands behind the patient. In view of the wider
diameter of the EBUS-TBNA scope, oral intubation is preferred. As described above the
endoscopic view is 30 degrees forward oblique, therefore the bronchoscope needs to be flexed
down in order to obtain a straight view. In order to pass the bronchoscope through the vocal
cords the anterior angle of the glottis should be visualized with the bronchoscope in the neutral
position. The mediastinal lymph nodes are examined by positioning the bronchoscope in the
correct anatomical position and then by flexing and pressing the ultrasound probe onto the
airway wall. The bronchoscope is adjusted so that the area for sampling is viewed in its
maximum diameter at the centre of the ultrasound image. The Doppler mode is used to
visualize vascular landmarks and can be used to identify vessels within lymph nodes. The size
of the lymph node is measured using the calipers.
2.2. The sampling technique
For a more detailed review of this aspect, the reader is directed to other sources [1]. Sampling
using the dedicated single use TBNA needle is ideally performed by two operators however
it is possible for the technique to be carried out with a single operator. Currently 2 sizes of
dedicated EBUS-TBNA sampling needles (21-gauge and 22-gauge) are available. The needle
is housed within a sheath which is inserted into the 2.0mm working channel of the EBUS
bronchoscope. The sampling needle has multiple small dimples along its shaft in order to
increase the echogenicity and screen visualisation. 21 gauge needles are often preferred for
suspected granulomatous disease as there is evidence to suggest that the histological structure
of specimens is better preserved using the larger needle [2, 3].
Following intubation, lymph nodes are identified according to the International Staging
System [4] with the aid of vascular landmarks and the Doppler mode. Mediastinal lymph
nodes at stations 2-4, 7, 10 and 11 can be accessed for EBUS-TBNA (figure 3). The EBUS-TBNA
sampling needle is inserted through the working channel and is positioned so that the tip of
the needle sheath is just visible on the endoscopic image. This is extremely important in order
to avoid damage to the bronchoscope channel when the needle exits. The needle is locked on
to the working channel and the internal stylet is withdrawn slightly. The depth for sampling
is determined (0.5-4 cm) and this distance is set using the safety calibrator (figure 4). Holding
the bronchoscope against the airway wall the needle is then inserted using a “jabbing”
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movement. The needle exits the working channel at angle of 20 degrees to the sheath of the
insertion tube (figure 5). Following insertion of the needle the internal stylet is advanced and
withdrawn within the needle lumen to clear any airway wall debris before it is completely
removed. A 3-way vacuum syringe is attached to the needle and sampling commences by
advancing and withdrawing the needle approximately 15 times within the node under direct
vision (figure 6). Once sampling is complete the 3-way syringe is disconnected and then the
needle is removed from the working channel. The internal stylet is used to expel the histological
core tissue sample from the needle lumen onto a specimen collecting system. The stylet is
removed and cleaned with saline and air is injected though the needle lumen to remove any
remaining particles. The same node is usually sampled 2 to 3 times assuming a good sample
is obtained at each pass. For benign disease such as granulomatous disease it may be preferable
to do a limited number of passes in a greater number of lymph nodes in order to limit the total
length of the procedure if conscious sedation is being used rather than general anaesthesia [5].
Figure 3. Diagrammatic representation of lymph node stations accessed via EBUS-TBNA/ EUS-FNA. EUS-FNA = endo‐
scopic ultrasound-guided fine needle aspiration.
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Figure 4. Sampling Needle inserted into working channel of EBUS scope
Figure 5. Tip of EBUS scope with balloon inflated and TBNA needle exiting
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Figure 6. Ultrasound image of lymph node with EBUS-TBNA sampling needle in situ
Figure 7. Histological sample obtained using EBUS-TBNA showing non-caseating granuloma
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2.3. The specimen
The handling of the histological and cytological samples is extremely important. The diagnosis
of sarcoidosis is established when clinical and radiological findings are supported by histo‐
logical or cytological evidence of non-caseating epithelioid cell granulomas. Granulomas are
defined by loose collections of non-pigmented epithelioid or spindle cell histiocytes with
lymphocytes, necrotic material and neutrophils. In sarcoidosis numerous granulomas can be
seen in FNA samples without evidence of necrosis [7]. It is important to exclude local sarcoid-
like reactions and infective causes.
Many centres choose to utilise rapid on-site evaluation (ROSE) of cytology samples in order
to confirm the adequacy of specimens however resources and cost are limiting factors. ROSE
of specimens has been shown to increase diagnostic yield in some circumstances, however a
recent meta-analysis examining the use of ROSE in cases of suspected sarcoidosis did not
demonstrate a statistically significant increase (p = 0.66) in yield in studies where ROSE was
carried out (165/206; 80.1% vs 282/347; 81.3%) [6]. ROSE allows a smaller number of passes to
be carried per node. Once a diagnosis of granulomatous disease or malignancy is reached
sampling of that particular node can be stopped. In order to minimize the number of false
negative results, if no malignancy or granulomatous inflammation is seen, further sampling
should be performed. Gross examination of the specimen can be helpful as adequate samples
often appear creamy (rather than bloody, watery or mucoid) or may be black as a result of
anthracosis [7].
Typically the EBUS-TBNA samples are smeared on to glass slides and air dried then fixed
however some centres prefer to use liquid cytology bottles. Tissue cores are fixed in formalin
or saline depending on whether culture for Mycobacterial disease is required. It has recently
been reported that cell block analysis in addition to the Diff-Quick smear examination can
reduce the false negative rate by 33%. Furthermore, Wang et al [8], found that of 37 patients
who had EBUS-TBNA carried out, 100% of cell blocks contained non-necrotizing granulomas
compared to 27% of smears. This may be because smearing samples between two slides
disrupts the epithelioid groups in FNA samples which does not tend to occur during cell block
preparation.
There is debate regarding the definition of an adequate tissue sample. In the absence of
malignant cells or granulomatous cells it is clearly important to confirm that an adequate
amount of lymphoid tissue is present in the sample. The negative predictive value of samples
is far superior when lymphocytes are detected. Attempts have been made to quantify the
number of cells required to define the adequacy of a sample. For example, [see 7] state that a
sample containing at least 40 benign-appearing lymphocytes in a high-power field in the areas
of highest cellularity of the smear constitutes an adequate sample. Likewise the identification
of large numbers of anthracotic pigment and macrophages or large clusters of admixed
lymphocytes and pigmented macrophages may further indicate an adequacy. If malignancy
or granulomatous disease is seen with small numbers of lymphocytes this can also be consid‐
ered to be adequate. The interpretation of adequacy is somewhat subjective and development
of a standardised approach may help to reduce the number of false negative or positive results.
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Sarcoid-like granulomata may be visualized in the context of malignancy such as non-small
cell lung cancer, lymphoid and germ cell neoplasms and are thought to be a result of a local T
cell-mediated immune reaction. It is therefore important to continue to attempt to exclude
malignancy even if granulomatous inflammation is seen. Similarly granulomatous inflamma‐
tion can be seen as a result of fungal or mycobacterial infections particularly in immunosup‐
pressed patients and appropriate culture should be considered. The implication of EBUS-
TBNA detection of granulomatous inflammation in patients with previously treated cancer
and new mediastinal lymphadenopathy has been examined [9]. In this study, 17/153 (11%) of
patients referred for EBUS-TBNA were found to have non-caseating granuloma. A subgroup
of patients had a previous history of cancer and presented with mediastinal lymphadenopathy
suspicious of cancer recurrence. All these patients had granulomatous inflammation con‐
firmed via EBUS-TBNA and remained clinically stable during follow-up. The study highlights
the importance of obtaining a tissue diagnosis in this subgroup of patients and supports the
utility of EBUS-TBNA as a diagnostic tool in this circumstance. The differentiation between
true sarcoidosis and sarcoid-like reaction must be made through clinical and radiological
correlation.
2.4. Diagnostic yield of EBUS-TBNA
The diagnostic yield of EBUS-TBNA in sarcoid has been reported between 80-90% [10]. It is
important to note that the highest sensitivity (92%) of EBUS-TBNA has been demonstrated in
patients with stage I and II disease with nodes of >10mm however even in patients with nodes
of <10mm and all stages of sarcoidosis the sensitivity is still adequate (85%) [11,12]. A recent
meta-analysis of 15 studies of EBUS-TBNA in sarcoidosis described a yield between 54-93%
with a pooled diagnostic accuracy of 79% (95% CI, 71-86%) however there was heterogeneity
between studies included. There was also variability regarding the experience of the operators
in these studies [6].
2.5. Contraindications
EBUS-TBNA is a well tolerated procedure. Patients should be fit enough to undergo flexible
bronchoscopy in accordance with local guidelines [13]. Biopsies should not be carried out in
patients who are currently taking warfarin and the international normalized ratio (INR) should
be less than 1.4. Clopidogrel is normally withheld at least one week prior to the procedure
although a small series of patients who had EBUS-TBNA whilst still taking clopidogrel (and
a significant proportion also taking aspirin) did not report any bleeding complications [14].
The procedure should be avoided for 6 weeks after myocardial infarction and should not
carried out in patients with arrhythmia or severe hypoxaemia at rest [15].
2.6. Complications
EBUS-TBNA has been shown to be a safe, minimally invasive technique. Only 5 minor
complications (minimal pneumothorax, minor bleeding, airway oedema/hypoxaemia,
prolonged coughing) were reported in a recent systematic review of 532 patients undergoing
EBUS-TBNA for suspected sarcoidosis [6]. Compared to mediastinoscopy which carries a 0.5%
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risk of major complications and 1.4-2.3% risk of significant complications the risk of compli‐
cations with EBUS-TBNA is lower [15]. Routine chest radiograph is not required following the
procedure unless the patient reports specific symptoms (e.g. chest pain) during or after the
procedure although some centres do a chest radiograph after sampling the hilar stations
routinely [16].
2.7. Costs
The main costs of setting up an EBUS-TBNA service are due to equipment costs such as the
EBUS bronchoscope, ultrasound processor and also the disposable EBUS needles (which are
more expensive than conventional TBNA needles) and accessories (approximately £150-175).
As the procedure takes longer than a conventional flexible bronchoscopy, the cost of additional
staff time must be considered. If ROSE is required this is a further cost. Repair and servicing
of the EBUS bronchoscope is more expensive than a flexible bronchoscope. Similar to conven‐
tional TBNA there is a risk of damage to the biopsy channel of the bronchoscope if the sheath
of the EBUS-TBNA needle is not positioned correctly when the needle is advanced. Having
taken into account the additional costs of EBUS-TBNA, since the technique has a higher
sensitivity than conventional TBNA (particularly where distal or smaller node sampling is
required, the overall cost saving potential from avoiding a mediastinoscopy is likely to be
greater with this technique than with conventional TBNA [15].
2.8. Training and learning curve
EBUS-TBNA can be performed by pulmonologists. Training requires the operator to have had
sufficient experience in all standard bronchoscopic techniques, including conventional TBNA.
Experience with the interpretation of ultrasound is also useful e.g. thoracic ultrasound.
Training of nursing staff is also required. The American College of Chest Physicians (ACCP)
recommends that in order to achieve competence in EBUS-TBNA, 50 supervised procedures
must be carried out. Furthermore in order to maintain competence it is recommended that a
minimum of 20 procedures per year are carried out [17]. The learning curve and the number
of procedures required to produce optimal results is high [18]. In fact a recent prospective
study has demonstrated improving results up to 120 procedures [19].
3. Other diagnostic bronchoscopic techniques
3.1. Conventional TBNA
The use of TBNA in the diagnosis of sarcoidosis has been described since the 1980’s. The
technique of sampling lymph nodes using this method is a blind technique and diagnostic
accuracy is likely to be dependant on the skill of the operator. The reported sensitivity of TBNA
is variable, ranging from 46-90% [3]. It is also a technique which is underutilised by pulmo‐
nologists (10-30% uptake) because of concerns regarding diagnostic yield and fear of vascular
injury [10]. There is also a belief that it is not useful (reported by 30% pulmonologists in one
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study) and concerns about performing the technique without onsite pathology support [20]..
EBUS-TBNA carries a lower risk of complications compared with conventional TBNA. Several
studies have directly compared EBUS-TBNA with conventional TBNA. In one, small prospec‐
tive study of patients with suspected sarcoidosis EBUS-TBNA was followed by conventional
TBNA. The two techniques were found to be of similar efficacy with a positive diagnosis
established in 93% of patients using EBUS-TBNA and/ or conventional TBNA [3]. Only one
randomised controlled trial has directly compared EBUS-TBNA with conventional TBNA. This
study demonstrated a superior diagnostic yield with EBUS-TBNA compared to conventional
TBNA (using a 19-gauge needle) in patients with suspected sarcoidosis. An absolute increase
in yield of 29.5% was demonstrated with EBUS-TBNA (p <0.05; 95% confidence interval 8.6 to
55.4%). Sensitivity and specificity in the conventional TBNA group was 60.9% and 100%
respectively compared with 83.3% and 100% in the EBUS-TBNA group. Of note, more lymph
nodes were sampled in the EBUS-TBNA group but more passes were required in the TBNA
group [21].
3.2. Bronchoalveolar Lavage (BAL)
BAL is a safe, minimally invasive and low cost technique which can be performed during
flexible bronchoscopy but can also be performed via the EBUS bronchoscope. BAL samples
can be used to support a diagnosis of sarcoidosis if a characteristic cytological predominance
of lymphocytes is seen. A CD4+/CD8+ ratio of greater than 3.5 in the lymphocyte population
has a high specificity (94%) for sarcoidosis. However a low ratio cannot be used to exclude a
diagnosis of sarcoidosis [22]. BAL is also of use for microbiological testing particularly where
mycobacterial disease is suspected.
3.3. Endobronchial and transbronchial lung biopsy
In patients with suspected sarcoidosis with evidence of parenchymal disease transbronchial
lung biopsy (TBLB) can be used to obtain a diagnosis however the reported diagnostic yield
is variable (44-90%) dependent on the number of sites sampled and the extent of the paren‐
chymal disease [23]. TBLB has limited value in stage I disease and unlike EBUS-TBNA, TBLB
carries a risk of pneumothorax and a higher risk of bleeding.
Endobronchial biopsy (EBB) can be carried out where there is evidence of airway involvement
and even if the airways do not appear grossly abnormal EBB can further increase the yield
with a 30% yield even in normal airways [24]. In practice EBB is typically performed when
macroscopic disease is visible. EBUS-TBNA has been demonstrated to have superior diagnos‐
tic utility when compared with TBLB and endobronchial biopsy [3,25,26].
3.4. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)
Transoesophageal  EUS-FNA  was  first  introduced  in  the  early  1990s  and  was  most
commonly used by gastroenterologists to obtain tissue from pancreatic lesions. Subsequent‐
ly this technique has been applied in the diagnosis of both intrabdominal and intrathora‐
cic lesions. EUS-FNA enables access to lymph node stations 2L, 4L and most importantly
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the lower mediastinum (7, 8, and 9). Nodes in the aortopulmonary window (5) and para-
aortic nodes (6) can be visualized however sampling is limited by the proximity of vascular
structures. The left adrenal gland and the left lobe of the liver can also be sampled. The
accuracy of EUS-FNA is greater with ROSE. The technique can be combined with EBUS-
TBNA  and  pulmonologists  can  train  to  carry  out  both  procedures  or  (if  appropriately
trained) alternatively intubate the oesophagus with the EBUS bronchoscope, as described
in  some  centres,  EUS-B-FNA  [27,  28].  The  disadvantage  of  EUS-FNA  without  EBUS-
TBNA is the range of nodes which can be accessed is more limited and it is not possible
to  sample  hilar  nodes.  This  is  of  particular  relevance  in  sarcoidosis  as  hilar  nodes  and
nodes anterolateral to the trachea are more commonly involved [7].
Diagnostic yield is high with EUS-FNA and has been reported as 82%, sensitivity 89% and
specificity 96% [29]. When combined with EBUS-TBNA the yield is improved further and the
range of nodes which can be sampled is greater.
3.5. Mediastinoscopy
Mediastinoscopy  has  been  considered  to  be  the  gold  standard  mediastinal  sampling
method  of  choice  particularly  if  other  techniques  such  as  TBLB  are  non-contributory.
Mediastinoscopy  is  an  invasive  technique  which  requires  a  general  anaesthetic  and  an
overnight hospital stay. There are several approaches which allow access to different nodal
stations and areas  of  the mediastinum. Cervical  mediastinoscopy (via  an incision at  the
suprasternal  notch)  allows  access  to  the  pretracheal,  upper  paratracheal  (2R,  2L),  lower
paratracheal (4R, 4L), subcarinal (7) and hilar (10) nodes. The extended cervical mediastino‐
scopy also allows access to the anterior mediastinum including pre-aortic (6) and aortopul‐
monary window (5)  nodes.  There are currently no studies comparing EBUS-TBNA with
mediastinoscopy  in  suspected  sarcoidosis.  Successful  diagnosis  with  EBUS-TBNA  may
obviate  the  need  for  mediastinoscopy.  This  is  not  only  likely  to  be  more  preferable  to
patients who may avoid an invasive procedure but there are also cost saving benefits as
discussed previously.
3.6. Peripheral lymph node biopsy
Sarcoidosis involving peripheral lymph nodes is frequently asymptomatic. The incidence
of peripheral lymph node involvement has been reported between 2-25%. High diagnos‐
tic yield with sampling of peripheral lymph nodes has been reported. In one study, at least
one  enlarged  peripheral  lymph  node  was  found  in  14.5%  (79/546)  of  patients  with  a
diagnosis of sarcoidosis [30]. The diagnostic yield of peripheral lymph node biopsy in these
patients  was  93% with  no  associated  complications  and significantly  a  lower  cost  com‐
pared to other techniques. The most common sites of involvement were the cervical nodes
(31.3%)  and  supraclavicular  nodes  (29.9%).  Ultrasound  guided  peripheral  lymph  node
biopsy may be an option in patients who have contraindications to mediastinal sampling
techniques.
The advantages and disadvantages of all these techniques are summarised in table 2.
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Technique Advantages over EBUS-TBNA Disadvantages over EBUS-TBNA
Conventional TBNA
Lower cost
More commonly performed by
pulmonologists
Shorter procedure time
Risk of complications/ injury (“blind”
technique)
Shorter needle throw therefore smaller
tissue core
Lower diagnostic yield
Less extensive range of node sampling
EBB Performed by pulmonologistsLower cost Lower diagnostic yield
TBLB Performed by pulmonologistsLower cost
Risk of complications
Less useful in the absence of
parenchymal disease
EUS-FNA Improved access to some lymph nodestations
Unable to access hilar nodes
More commonly performed by
gastroenterologists /radiologists
Mediastinoscopy Larger histological tissue sample obtainedHigh negative predictive value
Invasive procedure with risk of significant
complications
Generally performed by thoracic
surgeons
Requires general anaesthetic and
overnight hospital stay
Higher cost
Peripheral lymph node
biopsy
Low cost (especially if ultrasound-guided
without theatre)
Low complication rate
Small proportion of patients with
enlarged nodes
Table 2. Pros and cons of other non-EBUS sampling techniques in sarcoidosis involving mediastinum/nodal tissue
and/or lung
4. Advantages and disadvantages of EBUS-TBNA
4.1. Compared to conventional TBNA
Unlike conventional TBNA, EBUS-TBNA allows access to a wider range of lymph nodes
stations (2-4,7, 10 and 11) and therefore provides access to more distal locations. This is of
particular relevance in granulomatous disease where sampling of multiple nodal stations can
further increase diagnostic yield. This advantage is augmented further by combining EBUS-
TBNA with EUS-FNA thereby enabling access to even more lymph node stations.
Conventional TBNA is a blind technique and therefore carries a risk of bleeding through
potential damage to vascular structures. EBUS-TBNA carries a lower bleeding risk as it is
performed under real time ultrasound guidance. The use of Doppler mode imaging allows
accurate visualisation of vessels prior to sampling. Furthermore because sampling is carried
out under direct vision it is possible for the EBUS-TBNA needle to be inserted further into the
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sampling area with each pass compared with sampling during conventional TBNA. Larger
cores of tissue can therefore be obtained compared with conventional TBNA. Once again this
is particularly important in granulomatous disease.
The cost of equipment and additional staff time required in order to carry out EBUS-TBNA
makes it a more expensive technique when compared with conventional TBNA, however as
discussed earlier the overall cost saving gained from avoiding the need for mediastinoscopy
is likely to be greater for EBUS-TBNA than with conventional TBNA.
4.2. Compared to mediastinoscopy
Mediastinoscopy has been considered to be the gold standard mediastinal sampling method
of choice particularly if other techniques such as TBLB are non-contributory. Mediastinoscopy
is an invasive technique which requires a general anaesthetic and an overnight hospital stay
unlike EBUS-TBNA which is typically carried out under light conscious sedation as a day case
procedure. Clearly there are financial advantages to a less invasive approach and it is likely to
be more preferable to patients. Mediastinoscopy carries a risk of major complications (0.5%)
and 1.4-2.3% risk of significant complications such as supraventricular arrhythmias. It also
results in a neck scar and the development of adhesions following mediastinoscopy may
hinder future attempts at lymph node sampling [16]. Previous neck surgery is a relative
contraindication to mediastinoscopy. As discussed previously, the risk of complications with
EBUS-TBNA is lower than with mediastinoscopy. The range of nodes which are accessible via
EBUS-TBNA is greater than with mediastinoscopy particularly the hilar nodes. This is of
relevance in granulomatous disease as the hilar nodes are frequently affected.
Smaller tissue samples are obtained with EBUS-TBNA compared to mediastinoscopy and as
discussed earlier this can affect the adequacy of tissue samples obtained. For this reason the
negative predictive value of EBUS-TBNA is lower. This is particularly relevant when sampling
for malignancy. If there is concern that malignancy such as lymphoma is a possible cause for
lymphadenopathy, mediastinoscopy should be the sampling technique of choice. Alternative‐
ly, a non-diagnostic EBUS-TBNA result should be considered for further investigation with
mediastinoscopy. In experienced centres where adequate tissue samples are obtained through
EBUS-TBNA the technique may be an alternative option for patients who have been deemed
not fit for invasive mediastinoscopy.
5. Comparative studies of EBUS-TBNA with other mediastinal sampling
techniques
Combining EBUS-TBNA with standard bronchoscopic techniques has been shown to improve
diagnostic yield further. This is important as improved accuracy in non-invasive techniques
may obviate the need for mediastinoscopy. A number of studies have evaluated combining
EBUS-TBNA.
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A prospective study carried out in an experienced centre examining the safety and efficacy of
combining EBUS-TBNA with TBLB and EBB for the diagnosis of sarcoidosis in an unselected
group of patients [26] demonstrate a sensitivity of standard bronchoscopic techniques (TBLB
and EBB) of 35% (P<0.001) compared with 85% with EBUS-TBNA. Combining the two
techniques resulted in a diagnostic yield of 93% (P<0.0001). In this study the relatively low
sensitivity with TBLB and EBB was attributed to the fact that the majority of patients had stage
I sarcoidosis without evidence of parenchymal disease.
Another study in which patients with clinical and radiological evidence of sarcoidosis
underwent EBUS-TBNA, TBLB and BAL also supports a combined approach. The diagnostic
accuracy was superior with EBUS-TBNA compared with TBLB (p<0.001). Analysis of BAL
samples demonstrated that the CD4/CD8 ratio was >3.5 in 65.7% of patients with a final
diagnosis of sarcoidosis. The diagnostic yield for all modalities of sampling was very high
(100%) in patients with stage II sarcoidosis, however EBUS-TBNA was superior to all other
modalities for stage I disease. Of note, all patients underwent cross sectional imaging prior to
the procedure and had nodes measuring >10mm diameter. ROSE was also utilized [31].
There is evidence to support the use of combined flexible bronchoscopy and EUS-FNA +/-
EBUS-TBNA in order to increase diagnostic yield. Tournoy et al, confirmed this in a study of
patients with suspected sarcoidosis who did not have a definite diagnosis following standard
bronchoscopic techniques (TBNA, TBLB and EBB) [32]. These patients were sent for EBUS-
TBNA and/ or EUS-FNA. A definite diagnosis of sarcoidosis was established in 45% patients
following standard flexible bronchoscopic procedures. However diagnostic yield increased by
a further 39% with the addition of EBUS-TBNA and/ or EUS-FNA.
5.1. Newer techniques
EBUS-guided forceps or transbronchial needle forceps are currently under evaluation. This
sampling tool is a combination of a needle and forceps which can be passed through the
working channel of the EBUS scope. These forceps can potentially allow larger histological
cores of tissue to be obtained. An initial pilot study has shown this tool to be safe and specific
diagnosis was established in 86% of patients [33].
6. Conclusion
EBUS-TBNA is a safe, well tolerated and effective mediastinal sampling tool which can be used
in the diagnosis of suspected sarcoidosis. As with all mediastinal sampling techniques,
histological samples should be interpreted in the context of clinical and radiological findings.
EBUS-TBNA has been shown to have a higher diagnostic yield compared to conventional
bronchoscopic techniques such as EBB, TBLB and TBNA. Combining EBUS-TBNA with other
modalities such as EUS-FNA may further increase diagnostic yield as may the use of newer
sampling tools such as the transbronchial needle forceps. Improved accuracy and yield with
this technique may obviate the need for further invasive sampling attempts such as mediasti‐
noscopy. This consequently reduces the overall cost compared to other techniques and
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importantly reduces the potential for procedure related complications. Future studies are
required to further evaluate this technique in sarcoidosis as compared to existing sampling
techniques.
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